Catalyst Pharmaceuticals, Inc. (CPRX) Financials

CPRX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 471.9 million 84.0 million
2023-09-30 413.2 million 64.7 million
2023-06-30 443.9 million 68.6 million
2023-03-31 407.2 million 73.6 million

CPRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 19.6 million 4.3 million
2023-09-30 -34.2 million 3.8 million
2023-06-30 30.8 million 3.3 million
2023-03-31 12.0 million 2.9 million

CPRX Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 34.8 million
2023-09-30 -30.8 million
2023-06-30 37.8 million
2023-03-31 29.6 million

CPRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 137.6 million - 3.6 million
2023-09-30 121.0 million - 3.6 million
2023-06-30 178.8 million - 3.7 million
2023-03-31 148.2 million - 3.5 million

CPRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 113.8 million
2023-09-30 106.6 million
2023-06-30 113.7 million
2023-03-31 114.0 million

CPRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 36.1 million 2.0 million 13.1 million 28.9 million
2023-09-30 79.4 million 83.7 million 11.9 million 21.7 million
2023-06-30 - 4.0 million 10.1 million 18.3 million
2023-03-31 74000 3.6 million 12.0 million 17.8 million

CPRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 110.6 million 24.9 million
2023-09-30 102.7 million 14.2 million
2023-06-30 99.6 million 12.0 million
2023-03-31 85.4 million 9.9 million

CPRX

Price: $14.72

52 week price:
11.09
17.78

Payout Ratio Range:
-1019.05%
528.92%

Earnings Per Share: 0.63 USD

P/E Ratio: 25.45

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.7 million

Ebitda: -4.3 million

Market Capitalization: 1.8 billion

Links: